Published Apr 2, 2025
Richard Waines from DCVC Bio
Richard Waines from DCVC Bio delves into the world of biotech investing, detailing the firm's strategic focus on early-stage companies and the emerging influence of AI in revolutionizing drug development. He shares insights into his unique biotech career journey, balancing scientific passion with commercial ventures and highlighting how venture capital is pivotal in transforming innovative research into successful businesses.

Topics covered
Popular Clips
Episode Highlights
Related Episodes


Byron Thom, Investor, Mentor and Board Member
Answers 383 questions

Vasu Nadella from Vital Bio and Michael Helander from OTI Lumionics
Answers 383 questions

Antoine Nivard from Blank Ventures
Answers 383 questions

Wayne Pommen from Affirm
Answers 383 questions

Liran Belenzon from BenchSci
Answers 383 questions

Ryan Wilson from Walter
Answers 383 questions

Craig D'Cruze from Inverted Ventures
Answers 383 questions

Lewis Wynne-Jones from ThinkData Works
Answers 383 questions

Willson Cross from Borderless AI
Answers 383 questions

Moien Giashi from GreenSky Ventures
Answers 383 questions

Preston Pesek from NatML
Answers 383 questions

Akash Vaswani from Velocity Fund
Answers 383 questions

Vincent Xue
Answers 383 questions

Vaneezeh Siddiqui from Thomson Reuters Ventures
Answers 383 questions

Jonathan Wolkin from Deloitte Ventures
Answers 383 questions
